Plant KE et al. |
Intergenic transcription in the human beta-globin gene cluster. |
2001 |
Mol. Cell. Biol. |
pmid:11533239
|
Chen Lf W et al. |
Duration of nuclear NF-kappaB action regulated by reversible acetylation. |
2001 |
Science |
pmid:11533489
|
Vinatzer U et al. |
The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase. |
2001 |
Br. J. Haematol. |
pmid:11552981
|
Sawa H et al. |
Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. |
2001 |
Brain Tumor Pathol |
pmid:11908866
|
Xu D et al. |
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. |
2001 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:11274400
|
Seth KA and Majzoub JA |
Repressor element silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) can act as an enhancer as well as a repressor of corticotropin-releasing hormone gene transcription. |
2001 |
J. Biol. Chem. |
pmid:11278361
|
Matsuda E et al. |
Targeting of Krüppel-associated box-containing zinc finger proteins to centromeric heterochromatin. Implication for the gene silencing mechanisms. |
2001 |
J. Biol. Chem. |
pmid:11278721
|
Kim MS et al. |
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. |
2001 |
Nat. Med. |
pmid:11283670
|
Vigushin DM et al. |
Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. |
2001 |
Clin. Cancer Res. |
pmid:11309348
|
Magdinier F and Wolffe AP |
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. |
2001 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:11309512
|
Grande A et al. |
A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines. |
2001 |
Cell Death Differ. |
pmid:11313705
|
Wu Y et al. |
Negative regulation of bcl-2 expression by p53 in hematopoietic cells. |
2001 |
Oncogene |
pmid:11313951
|
Ullerås E et al. |
Inhibition of histone deacetylase activity causes cell type-specific induction of the PDGF-B promoter only in the absence of activation by its enhancer. |
2001 |
Exp. Cell Res. |
pmid:11640883
|
Arthur JL et al. |
Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. |
2001 |
J. Virol. |
pmid:11264377
|
Laribee RN and Klemsz MJ |
Loss of PU.1 expression following inhibition of histone deacetylases. |
2001 |
J. Immunol. |
pmid:11673528
|
Biade S et al. |
Chemical agents that promote chromatin compaction radiosensitize tumour cells. |
2001 |
Int. J. Radiat. Biol. |
pmid:11682008
|
Mishra SK et al. |
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells. |
2001 |
FEBS Lett. |
pmid:11682064
|
Sharma M and Sun Z |
5'TG3' interacting factor interacts with Sin3A and represses AR-mediated transcription. |
2001 |
Mol. Endocrinol. |
pmid:11682623
|
Lavoie R et al. |
Design and synthesis of a novel class of histone deacetylase inhibitors. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11597413
|
Bernhard D et al. |
Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts. |
2001 |
Cell Death Differ. |
pmid:11598799
|